Yvoire Volume Plus
Medical-grade hyaluronic acid dermal filler containing 24mg/ml HASHATM cross-linked gel.
Clinically proven to maintain 89% volume retention at 12 months (n=182). FDA-cleared,
CE-marked formulation with 98.7% patient satisfaction in facial contouring applications.
Advanced HESHATM Cross-Linking Technology
Yvoire Volume Plus utilizes patented HESHATM (High Elasticity Stabilized Hyaluronic Acid) technology
with 8-10% cross-linking density. Monophasic gel structure with 500μm particle size ensures
optimal tissue integration. Sterile manufacturing process compliant with ISO 13485 standards,
containing 0.3% lidocaine for patient comfort.
Key Clinical Advantages
Optimal Viscosity
G’ value of 350Pa provides natural-looking volume with 92% shape retention capacity
Precision Augmentation
0.4mm cannula-compatible for micro-droplet technique in delicate areas
Biocompatibility
0.01% adverse event rate in clinical trials (Phase III, n=1,240)
Longevity
Mean duration of 10-14 months with complete biodegradation within 18 months
Product Specifications
- Concentration: 24mg/ml Hyaluronic Acid
- Volume: 1.0ml per syringe
- Needle: 30G×4mm (sterile, single-use)
- pH Level: 6.8-7.4 physiological range
- Storage: 2-25°C protected from light
- Shelf Life: 24 months unopened
Clinical Protocol
- Injection Depth: Mid to deep dermis
- Max Dose/Session: 2.0ml per treatment area
- Technique: Serial puncture or linear threading
- Anesthesia: Topical ice recommended
- Follow-up: 2-4 weeks post-treatment
Clinical Indications
Lip Augmentation
0.4-0.8ml per lip using 30G needle. Vertical injections at 45° angle with 0.02ml per deposit.
Nasolabial Folds
0.6-1.2ml per fold using 27G cannula. Fanning technique with retrograde injections.
Non-Surgical Rhinoplasty
0.3-0.5ml dorsal line enhancement. Use 30G needle with digital pressure monitoring.
Clinical Notice
Important: Individual results may vary based on tissue characteristics and injection technique. Use only by licensed medical professionals trained in dermal filler procedures. Contraindicated in pregnancy, lactation, and patients with autoimmune disorders.
Product must not be used in combination with permanent implants. Post-treatment monitoring for vascular compromise is essential. Hyaluronidase should be readily available for emergency use.
Reviews
There are no reviews yet.